Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the nuances that follow the news. In Aerospace news this week… Lockheed Martin-Built GOES-U Weather Satellite Successfully Launched An advanced weather satellite built by Lockheed Martin for the National Oceanic and Atmospheric Administration (NOAA)… Continue reading Read Magazine’s Weekly Roundup: Discover the Most Recent News Lockheed Martin, AbbVie, E2open, Abbott and More !
Tag: Biotechnology
AbbVie Acquires Celsius Therapeutics
AbbVie announced the acquisition of Celsius Therapeutics, Inc., a privately held biotechnology company pioneering new therapies for patients with inflammatory disease. Celsius’ lead investigational asset is CEL383, a potential first-in-class anti-TREM1 antibody that has completed a Phase 1 clinical study for the treatment of IBD. TREM1 has been identified as a key disease driver gene… Continue reading AbbVie Acquires Celsius Therapeutics
RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services
RareCyte, Inc. a Life Sciences company providing advanced Precision Biology platforms including instruments, reagents, software, and services announced the completion of a $20M financing from new and existing investors. The funding is expected to enable the Company to drive an expansion of the successful Orion Spatial Biology platform including commercializing new multiplex assays, reagent products, and… Continue reading RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services
Cellares Announces Agreement with Kite to Evaluate Its Cell Shuttle Automated Manufacturing Platform
Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, announced that Kite, a Gilead Company, will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle. The data generated in this proof-of-concept evaluation will be utilized to assess viability of the Cell Shuttle as a future manufacturing option for… Continue reading Cellares Announces Agreement with Kite to Evaluate Its Cell Shuttle Automated Manufacturing Platform
Kneat and Körber Pharma Consulting Partner to Accelerate Life Sciences Digitalization
kneat.com, inc., a leader in digitizing and automating validation and quality processes, is pleased to announce that it has signed a partnership agreement with leading international technology group, Körber, and its pharma consulting experts from the Körber Pharma Consulting GmbH. The agreement expands Kneat’s go-to-market by enabling Körber to resell and implement Kneat Gx, and offer… Continue reading Kneat and Körber Pharma Consulting Partner to Accelerate Life Sciences Digitalization
Daicel Arbor Biosciences launches new myTXTL® kits to accelerate protein expression
Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering. These powerful new kits include the myTXTL Pro Kit and the myTXTL Antibody/DS Kit, providing researchers with versatile tools to enhance throughput of their protein… Continue reading Daicel Arbor Biosciences launches new myTXTL® kits to accelerate protein expression
MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, announced the appointment of Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (CMO). Dr. Azoulay is an accomplished physician-scientist with over 35 years of experience in drug development and… Continue reading MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer
Parse Biosciences Announces Partnership with Gencell Pharma to Extend its Reach in South America
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced an agreement with Bogotá, Colombia-based Gencell Pharma to extend Parse’s reach in Colombia specifically and also across South America. “Demand for Parse’s Evercode single cell sequencing solutions continues to grow in South America as the academic, biotech, and pharma communities discover… Continue reading Parse Biosciences Announces Partnership with Gencell Pharma to Extend its Reach in South America
BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial
BlueSphere Bio, a drug development company focused on novel T-cell receptor (TCR) based therapies for oncology and non-oncology indications, announced a collaboration with NMDP BioTherapies℠ (formerly Be The Match BioTherapies), an organization offering solutions for companies developing and commercializing cell and gene therapies, to advance BlueSphere’s first clinical trial evaluating a novel cell therapy for patients… Continue reading BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial
Arialys Therapeutics Appoints Peter Flynn, Ph.D., President and Chief Executive Officer
Arialys Therapeutics, a biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, announced the appointment of Peter Flynn, Ph.D., as President and Chief Executive Officer. Dr. Flynn has more than 20 years of executive leadership experience in the biotech industry, from private start-ups to established publicly traded companies, scaling companies through key financings and pharma… Continue reading Arialys Therapeutics Appoints Peter Flynn, Ph.D., President and Chief Executive Officer